The pharmacologic treatment of depression

Am J Psychother. 1979 Jan;33(1):96-106. doi: 10.1176/appi.psychotherapy.1979.33.1.96.

Abstract

This article focuses on the treatment of depression with special reference to pharmacotherapy. The treatment-resistant case and the possible means of resolving its problems are highlighted. The role of ECT will be considered. Long-term maintenance treatment with antidepressant medication for patients with cyclic occurrences is recommended.

MeSH terms

  • Amphetamine / therapeutic use
  • Anti-Anxiety Agents / therapeutic use
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Antipsychotic Agents / therapeutic use
  • Deanol / therapeutic use
  • Depression / drug therapy*
  • Dose-Response Relationship, Drug
  • Humans
  • Lithium / therapeutic use
  • Methylphenidate / therapeutic use
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Phenmetrazine / therapeutic use
  • Piperidines / therapeutic use

Substances

  • Anti-Anxiety Agents
  • Antidepressive Agents, Tricyclic
  • Antipsychotic Agents
  • Monoamine Oxidase Inhibitors
  • Piperidines
  • Methylphenidate
  • Deanol
  • Lithium
  • Amphetamine
  • Phenmetrazine